LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) reminds investors of the March 20, 2017 deadline to file a lead plaintiff motion in the class action filed by GPM on behalf of a class (the “Class”) of investors who purchased OneMain Holdings, Inc. (“OneMain” or the “Company”) (NYSE: OMF) securities between March 3, 2015 and November 7, 2016, inclusive (the “Class Period”). OneMain investors have until March 20, 2017 to file a lead plaintiff motion.
OneMain, through its subsidiaries, provides consumer finance and insurance products and services. The Company has historically focused on providing credit to subprime borrowers, and as a result spends considerable amounts of time and effort on its collection practices.
According to the complaint filed in this lawsuit, defendants made materially misleading representations and/or omitted material information regarding the net income and potential synergies achievable through the combination of OneMain with Springleaf. When the combined entities failed to perform as promised, investors suffered damages.
If you purchased or otherwise acquired shares of OneMain during the Class Period you may move the Court no later than March 20, 2017 to request appointment as lead plaintiff. To be a member of the class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to firstname.lastname@example.org, or visit our website at http://www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.